- Home
- BMRA vs SBFM Comparison
BMRA vs SBFM Comparison
Compare BMRA & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- SBFM
- Stock Information
- Founded
- BMRA 1971
- SBFM 2006
- Country
- BMRA United States
- SBFM United States
- Employees
- BMRA N/A
- SBFM N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- SBFM Health Care
- Exchange
- BMRA Nasdaq
- SBFM Nasdaq
- Market Cap
- BMRA 5.9M
- SBFM 6.8M
- IPO Year
- BMRA N/A
- SBFM N/A
- Fundamental
- Price
- BMRA $0.84
- SBFM $2.45
- Analyst Decision
- BMRA
- SBFM Strong Buy
- Analyst Count
- BMRA 0
- SBFM 1
- Target Price
- BMRA N/A
- SBFM $15.00
- AVG Volume (30 Days)
- BMRA 1.5M
- SBFM 52.5K
- Earning Date
- BMRA 04-11-2025
- SBFM 03-27-2025
- Dividend Yield
- BMRA N/A
- SBFM N/A
- EPS Growth
- BMRA N/A
- SBFM N/A
- EPS
- BMRA N/A
- SBFM N/A
- Revenue
- BMRA $5,578,000.00
- SBFM $32,959,491.00
- Revenue This Year
- BMRA N/A
- SBFM $59.94
- Revenue Next Year
- BMRA N/A
- SBFM $164.69
- P/E Ratio
- BMRA N/A
- SBFM N/A
- Revenue Growth
- BMRA 1.40
- SBFM 61.94
- 52 Week Low
- BMRA $0.24
- SBFM $2.11
- 52 Week High
- BMRA $1.35
- SBFM $286.00
- Technical
- Relative Strength Index (RSI)
- BMRA 60.77
- SBFM 38.35
- Support Level
- BMRA $0.53
- SBFM $2.39
- Resistance Level
- BMRA $1.10
- SBFM $2.58
- Average True Range (ATR)
- BMRA 0.11
- SBFM 0.15
- MACD
- BMRA 0.02
- SBFM -0.01
- Stochastic Oscillator
- BMRA 61.04
- SBFM 14.89
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.